Kezar Life Sciences, Inc. (Nasdaq: KZR), the stock soared 17.65% to $6.5 in the after-hours session following the biotechnology firm disclosed that it was added to the NASDAQ Biotech Index (Nasdaq: NBI), effective before market opening on Monday 21 December 2020.
The NASDAQ Biotechnology Index is intended to measure stocks’ success traded on the Nasdaq Stock Exchange (Nasdaq), categorized under the Industry Classification Benchmark as either biotechnology or pharmaceutical (ICB). Under an updated capitalization-weighted algorithm, the NASDAQ Biotechnology Index is calculated.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
NASDAQ Biotechnology Index firms must meet eligibility rules, including minimum market capitalization, estimated daily trading volume and, among other factors, seasoning as a public company. In December, Nasdaq selects constituents once per annum. For more information about the NASDAQ.
